|
AASDHPPT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.879000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.036770E-01 |
| Normal-vs-Stage2 |
5.522800E-01 |
| Normal-vs-Stage3 |
1.221740E-02 |
| Normal-vs-Stage4 |
4.372700E-04 |
| Stage1-vs-Stage2 |
8.632200E-01 |
| Stage1-vs-Stage3 |
1.580960E-01 |
| Stage1-vs-Stage4 |
1.568290E-02 |
| Stage2-vs-Stage3 |
3.768200E-01 |
| Stage2-vs-Stage4 |
1.643560E-01 |
| Stage3-vs-Stage4 |
4.305800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.090000E-02 |
| Normal-vs-AfricanAmerican |
4.430900E-04 |
| Normal-vs-Asian |
1.749000E-01 |
| Caucasian-vs-AfricanAmerican |
4.491600E-02 |
| Caucasian-vs-Asian |
7.578600E-01 |
| AfricanAmerican-vs-Asian |
7.189400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.480110E-03 |
| Normal-vs-Female |
3.204200E-01 |
| Male-vs-Female |
4.082000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.835100E-03 |
| Normal-vs-Age(41-60Yrs) |
7.959500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.074120E-02 |
| Normal-vs-Age(81-100Yrs) |
1.007010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.892620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.152600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.994400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.457000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.436800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.396400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.181800E-01 |
| Normal-vs-Grade 2 |
5.036000E-01 |
| Normal-vs-Grade 3 |
1.984570E-03 |
| Normal-vs-Grade 4 |
1.89838999999914E-05 |
| Grade 1-vs-Grade 2 |
9.292000E-01 |
| Grade 1-vs-Grade 3 |
3.545600E-01 |
| Grade 1-vs-Grade 4 |
5.236400E-02 |
| Grade 2-vs-Grade 3 |
3.050400E-02 |
| Grade 2-vs-Grade 4 |
3.393500E-04 |
| Grade 3-vs-Grade 4 |
3.365900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.844200E-01 |
| Normal-vs-ccB subtype |
3.433000E-04 |
| ccA subtype-vs-ccB subtype |
1.93416999999529E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.211600E-02 |
| Normal-vs-N1 |
1.843570E-01 |
| N0-vs-N1 |
4.817800E-01 |
|
|
